Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis

AIMS: The preferred antithrombotic strategy for secondary prevention in patients with cryptogenic stroke (CS) and patent foramen ovale (PFO) is unknown. We pooled multiple observational studies and used propensity score-based methods to estimate the comparative effectiveness of oral anticoagulation...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Eur Heart J
Asıl Yazarlar: Kent, David M., Dahabreh, Issa J., Ruthazer, Robin, Furlan, Anthony J., Weimar, Christian, Serena, Joaquín, Meier, Bernhard, Mattle, Heinrich P., Di Angelantonio, Emanuele, Paciaroni, Maurizio, Schuchlenz, Herwig, Homma, Shunichi, Lutz, Jennifer S., Thaler, David E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2015
Konular:
Clinical Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4568404/
https://ncbi.nlm.nih.gov/pubmed/26141397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehv252
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller